Omblastys Den Europæiske Union - dansk - EMA (European Medicines Agency)

omblastys

y-mabs therapeutics a/s - iodine (131i) omburtamab - neuroblastom - terapeutiske radioaktive lægemidler - treatment of neuroblastoma.

Mammit-io 3 mg/ml pattebadevand, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

mammit-io 3 mg/ml pattebadevand, opløsning

ferdinand eimermacher gmbh & co. - iod - pattebadevand, opløsning - 3 mg/ml - kvæg

Tekcis radionuklidgenerator Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

tekcis radionuklidgenerator

cis bio international oris ind. - natriummolybdat (99m-mo) - radionuklidgenerator

Thyrogen Den Europæiske Union - dansk - EMA (European Medicines Agency)

thyrogen

sanofi b.v. - thyrotropin alfa - thyroid neoplasms - hypofyseforlaps lap hormoner og analoger, hypofyse og hypothalamus hormoner og analoger - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.